Mucormycosis: Why Incidence Rate is more in Covid-19 patients

Neha Abhishek Sharma

Year: 2021
Volume: 11
Issue: 4

Mucormycosis: Why Incidence Rate is more in Covid-19 patients

Author:
Neha Abhishek Sharma^*
Total Page Count: 2
DOI: 10.52711/2349-2996.2021.00139
Page Number: 599 to 600

Vice-Principal, Ambaji Nursing College, Ganeshpura, Gujarat

^*Corresponding Author Email: pandeyn970@gmail.com

Online Published on 03 May, 2025.

Abstract

This article aims to review existing evidence and evaluate the documented reasons of high association of Mucormycosis with Covis-19 patients. A literature search was conducted using CDC, MedlinePlus, PubMed, Medscape and Researchgate databases.

Keywords

Mucormycosis, Diabetic ketoacidosis, Antifungal medications, Covid-19

Mucormycosis: Why Incidence Rate is more in Covid-19 patients

Abstract

Keywords

Products

Company

Account

Support